Eugenia Piras
Cagliari, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Real-world approaches to preventing acute myeloid leukemia relapse after allogeneic transplantation: a national survey by GITMO (Gruppo Italiano Trapianto Midollo Osseo).
Journal: Bone marrow transplantation
Published: April 01, 2026
Treatment of Acute Myeloid Leukemias and Myelodisplastic Syndromes Relapsing After Allogeneic Stem Cell Transplantation: An In-Depth Analysis of the GITMO AML/MDS-Relapse Registry Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 22, 2026
Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) GVHD24 Study.
Journal: American journal of hematology
Published: August 22, 2025
Outcome of Patients With Acute Myeloid Leukemias or Myelodysplastic Syndromes After Relapsing From Allogeneic Stem Cell Transplantation: The GITMO AML/MDS-Relapse Registry Study.
Journal: American journal of hematology
Published: March 17, 2025
Impact of primary cancer history and molecular landscape in therapy-related myeloid neoplasms.
Journal: Frontiers in oncology
Published: January 20, 2025
Assessment of frailty and comorbidities in cellular therapies patients in Italy: results of the GITMO Elderly-Survey (GITMO ELD-Survey).
Journal: Leukemia & lymphoma
Published: January 15, 2025
VEXAS syndrome: is it more a matter of inflammation or hematopoietic clonality? A case series approach to diagnosis, therapeutic strategies and transplant management.
Journal: Annals of hematology
Published: December 01, 2024
Three is better than two: humoral response in allogeneic HSCT after the third BNT162b2 SARS-CoV-2 mRNA vaccine.
Journal: European review for medical and pharmacological sciences
Published: August 22, 2023
Health-Related Quality-of-Life Profile of Pediatric Patients with β Thalassemia after Hematopoietic Stem Cell Transplantation.
Journal: Journal of clinical medicine
Published: August 03, 2023
Chronic graft vs. host disease and hypogammaglobulinemia predict a lower immunological response to the BNT162b2 mRNA COVID-19 vaccine after allogeneic hematopoietic stem cell transplantation.
Journal: European review for medical and pharmacological sciences
Published: December 16, 2022
Long-term health-related quality of life in patients with β-thalassemia after unrelated hematopoietic stem cell transplantation.
Journal: Bone marrow transplantation
Published: June 15, 2022
Last Updated: 09/26/2026